We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · April 12, 2021

PPM1D Mutations in Patients With Myelodysplastic Syndrome and Deletion of Chromosome 5q

American Journal of Hematology

 

Additional Info

American Journal of Hematology
Impact of PPM1D Mutations in Patients With Myelodysplastic Syndrome and Deletion of Chromosome 5q
Am. J. Hematol 2021 Mar 16;[EPub Ahead of Print], V Panagiota, M Meggendorfer, AS Kubasch, R Gabdoulline, J Krönke, A Mies, R Shaswar, C Kandziora, P Klement, J Schiller, G Göhring, C Haferlach, C Ganster, K Shirneshan, A Gutermuth, C Thiede, U Germing, T Schroeder, G Kobbe, S Klesse, C Koenecke, B Schlegelberger, N Kröger, D Haase, K Döhner, WR Sperr, P Valent, A Ganser, F Thol, T Haferlach, U Platzbecker, M Heuser

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading